Richcore: Analyst Corner: Laurus Labs' strength is adding new revenue streams
Laurus has announced acquisition of 72.55% stake in Richcore Lifesciences, a Bangalore-based company for a consideration of Rs 2.5 bn, valuing Richcore at Rs 3.4 bn.
Read full article »
Richcore is a biotechnology company that researches and develops novel enzymatic solutions for manufacturing biological drugs.
Read more